Jaguar Health converts Series O Preferred Stock to common at 3.209:1, pays $2.68 for fractions

Jaguar Health, Inc.

Each share of Series O Preferred Stock converted into 3.209 common shares on June 25, 2026; fractional shares paid in cash at $2.68/share.
Preferred stock was issued as a one-time stock dividend to common stockholders and warrant holders of record March 2, 2026.
Company targeting Breakthrough Therapy designation for crofelemer in MVID with NDA filing planned for H1 2027.
Initial MVID patient in proof-of-concept trial showed up to 37% reduction in parenteral support needs; data presented at ESPGHAN June 2026.
First Amendment to supply agreement with Woodward clarifies inventory title transfer and transition period through Dec 31, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.